Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression
Jieheng Wu, Xinlei Liu, Jiangwei Wu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 11, pp. 166521-166521
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The role of CXCL family members in different diseases
Chenjia Zhou, Ying Gao, Peilun Ding, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 88
Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy
Oliwia Piwocka, Igor Piotrowski, Wiktoria Maria Suchorska, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 19
Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance
Anastasia N. Kazakova, Maria M. Lukina, Ksenia S. Anufrieva, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 8
Blockade of V‐domain immunoglobulin suppressor of T‐cell activation reprograms tumour‐associated macrophages and improves efficacy of PD‐1 inhibitor in gastric cancer
Yifan Cao, Kuan Yu, Zihao Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 7
Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinoma
Di Wu, Yibing Liu, Jianjun Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
IL‐8 from CD248‐expressing cancer‐associated fibroblasts generates cisplatin resistance in non‐small cell lung cancer
Jieheng Wu, Qiaoling Zhang, Jiangwei Wu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 4
Open Access | Times Cited: 4
CD248-expressing cancer-associated fibroblasts induce epithelial–mesenchymal transition of non-small cell lung cancer via inducing M2-polarized macrophages
Jing Xiao, Zeyang Yang, Siyu Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
CD248‐expressing cancer‐associated fibroblasts induce non‐small cell lung cancer metastasis via Hippo pathway‐mediated extracellular matrix stiffness
Jiangwei Wu, Qiaoling Zhang, Zeyang Yang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access | Times Cited: 4
CD105+ fibroblasts support an immunosuppressive niche in women at high risk of breast cancer initiation
Eric G. Carlson, Jennifer C. Lopez, Yukiko Yamaguchi, et al.
Research Square (Research Square) (2025)
Closed Access
Pan-cancer analysis identified CD248 as a potential target for multiple tumor types
Li Guo, Yan Liao, Xuyang Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles
Xinxin Meng, Feng‐Yun Ma, Dingli Yu
Environmental Research (2023) Vol. 240, pp. 117362-117362
Closed Access | Times Cited: 10
Integrative analysis of cancer-associated fibroblast signature in gastric cancer
Zidan Zhao, Tsz Kin Mak, Yuntao Shi, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19217-e19217
Open Access | Times Cited: 9
Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy
Haebeen Jung, Silke Paust
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Non-immune cell components in tumor microenvironment influencing lung cancer Immunotherapy
Jingtao Zhang, Shuai Liu, Xiubao Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115336-115336
Open Access | Times Cited: 8
Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches
Shiqi Lu, Lunbiao Gan, Tong Lu, et al.
Theranostics (2023) Vol. 14, Iss. 1, pp. 379-391
Open Access | Times Cited: 7
ptx3a+ fibroblast/epicardial cells provide a transient macrophage niche to promote heart regeneration
Jisheng Sun, Elizabeth Peterson, Xin Chen, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114092-114092
Open Access | Times Cited: 2
Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment
Wenqiang Li, Quan Yuan, Mei Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma
Jun Jiang, Chao Xu, Donghui Han, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
The mechanism of cytokine regulation of cancer occurrence and development in the tumor microenvironment and its application in cancer treatment: a narrative review
Rongjun Qu, Yanhong Zhao, Y. Zhang
Translational Cancer Research (2024) Vol. 13, Iss. 10, pp. 5649-5663
Open Access | Times Cited: 2
TEM1 up-regulates MMP-2 and promotes ECM remodeling for facilitating invasion and migration of uterine sarcoma
Chenghao Wu, Wenhuizi Sun, Dongsheng Shen, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Chemokines: Function and therapeutic potential in bone metastasis of lung cancer
Dezhou Cheng, Jiancheng Wang, Yiling Wang, et al.
Cytokine (2023) Vol. 172, pp. 156403-156403
Closed Access | Times Cited: 6
miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154906-154906
Closed Access | Times Cited: 6
L3MBTL3 Is a Potential Prognostic Biomarker and Correlates with Immune Infiltrations in Gastric Cancer
Lin Gan, Changjiang Yang, Long Zhao, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 128-128
Open Access | Times Cited: 5
CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma
Guang Wang, Juan Fu, Mulin Liu, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0277872-e0277872
Open Access | Times Cited: 1
Boosting immune responses in lung tumor immune microenvironment: A comprehensive review of strategies and adjuvants
Fei Gao, Xiaoqing You, Liu Yang, et al.
International Reviews of Immunology (2024) Vol. 43, Iss. 5, pp. 280-308
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top